BioMed X has entered a new research collaboration with F. Hoffmann-La Roche in the field of immunology. BioMed X will launch a global call for applications to establish a new biomedical research group in Heidelberg. The goal the new group will be to develop novel approaches for the treatment of several immune-mediated diseases. Roche is seeking to identify key checkpoints and master switches governing functional adaptation of myeloid cells, which are capable of diverse functions in the immune...